The National Sanitary Surveillance Agency (Anvisa) approved the opening of four public consultations to update the rules for the processing and reuse of medical devices in the country.¹. The proposals seek more security and standardization for the sector.
The topic is currently regulated, among other standards, by RDC No. 156/2006 and by RE Resolutions No. 2.605/2006 and No. 2.606/2006. The new proposals aim to revise this model in light of technological advances and the need for more robust technical criteria².
Why revise the existing model
The Regulatory Impact Analysis (AIR) conducted by the Agency highlighted the discrepancy between current standards and the rapid technological evolution of the sector³.
Two factors exposed gaps that require standardization and legal certainty:
- the absence of periodic reviews in the list of products prohibited from being reprocessed; and
- the emergence of complex technologies classified as single-use without clear technical justification.
The main change proposed is the improvement of the criteria for classifying devices and the processing requirements, with greater emphasis on scientific evidence, risk management, the validation of procedures, and traceability. The goal is to preserve the safety, integrity, and performance of devices.
The four proposals under consultation
- Public Consultation No. 1420: new requirements for good processing practices (cleaning, disinfection and sterilization) in the Material and Sterilization Centers (CME) of hospitals, clinics and surgical centers.
- Public Consultation No. 1421: good processing practices in outsourced companies that provide healthcare services, with requirements such as a Certificate of Operation to carry out these activities.
- Public Consultation No. 1422: quality assurance guidelines for the development, validation, and control of processing protocols.
- Public Consultation No. 1423: criteria for classifying devices as single-use or reusable, according to the manufacturer's design.
Revocation of the list of prohibited items and new prohibitions
Public Consultation No. 1,423 proposes repealing Resolution RE No. 2,605/2006, which prohibits the reprocessing of 66 items.
The proposal also provides for the prohibition of:
- the sale and import of used or processed devices for reuse; and
- reuse of implantable, absorbable products that contain medication and products that have come into contact with cytostatic or radiopharmaceutical agents.
Timeframe and form of participation
The deadline for contributions in the four consultations began on October 1, 2026, and ends on January 28, 2027. Submissions must be made using the form available on the Anvisa official website.
The proposals aim to improve the quality of healthcare services and protect patients through technical evaluation and validation by health authorities regarding reuse and processing. Therefore, the contribution of healthcare professionals, manufacturers, distributors, and importers is of great importance in supporting the Collegiate Board in drafting the new resolutions.
Issues such as the repeal of the list of prohibited substances and the model for processing companies are under discussion. Until the publication of the final regulations, special attention is needed for the upcoming developments.
Reuse of medical devices: what is on the agenda
Which current regulations are under review by the Anvisa consultations?
DRC No. 156/2006 and the RE Resolutions No. 2.605/2006 and No. 2.606/2006, which deal with the processing and reuse of medical devices and the list of items with prohibited reprocessing.
How should the classification of single-use or reusable products change?
Public Consultation No. 1,423 proposes that the classification be based on the manufacturer’s design and technical criteria, replacing the fixed list of 66 items.
Until when and how to send contributions?
Until January 28, 2027, by a form available on the Anvisa official website, in each of the four consultations.
Life Sciences and Healthcare
The Life Sciences and Healthcare practice of Fialdini Einsfeld Advogados (FEADV) It works on regulatory issues in the healthcare sector, closely monitoring the initiatives of Anvisa and other regulatory bodies that impact manufacturers, distributors, importers, and healthcare service providers.
References
- KROLL, Rebeca. Anvisa proposes new rules for the reuse of medical devices. Future of Health, 2026
- Anvisa revises the rules on the reuse of medical devices that have been in effect since 2006. Abimed, 2026
- SOARES, Vilhena. Anvisa: public consultations will discuss the reuse of medical devices. JOTA, 2026